Relmada Therapeutics (RLMD) Shares Outstanding (Diluted) (2014 - 2026)
Relmada Therapeutics (RLMD) recorded Weighted Average Shares Outstanding (Diluted) of 112.38 million in Q2 2026, up 238.6% from 33.19 million a year earlier and up 29.8% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Shares Outstanding (Diluted) (2014 - 2026) Analysis & Trends
For FY2025, Relmada Therapeutics reported Weighted Average Shares Outstanding (Diluted) of 39.48 million, up 30.9% from FY2024.
- Annual Weighted Average Shares Outstanding (Diluted) has increased for five straight years, with a five-year compound annual growth rate of 67.3% (FY2020 to FY2025).
- Across earlier years, Weighted Average Shares Outstanding (Diluted) came in at 30.16 million in FY2024 (+0.2%), 30.1 million in FY2023 (+1.6%), 29.63 million in FY2022 (+68.8%) and 17.55 million in FY2021 (+483.3%).
- The Q2 2026 figure is the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q4 2014.
- On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has increased for 22 consecutive quarters, with growth averaging 59.5% over the last eight quarters.
- Over the past five years, the year-over-year growth in Weighted Average Shares Outstanding (Diluted) ranged from 0.1% (Q1 2024) to 483.3% (Q4 2021).
- Per Business Quant, the preceding three quarters came in at 86.6 million (Q1 2026), 39.48 million (Q4 2025) and 33.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Relmada Therapeutics | 455.48 Mn | -103.11 Mn | - | 112.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 112.38 Mn |
| Mar 31, 2026 | 86.60 Mn |
| Dec 31, 2025 | 39.48 Mn |
| Sep 30, 2025 | 33.19 Mn |
| Jun 30, 2025 | 33.19 Mn |
| Mar 31, 2025 | 30.41 Mn |
| Dec 31, 2024 | 30.16 Mn |
| Sep 30, 2024 | 30.17 Mn |
| Jun 30, 2024 | 30.17 Mn |
| Mar 31, 2024 | 30.13 Mn |
| Dec 31, 2023 | 30.10 Mn |
| Sep 30, 2023 | 30.10 Mn |
| Jun 30, 2023 | 30.10 Mn |
| Mar 31, 2023 | 30.10 Mn |
| Dec 31, 2022 | 29.63 Mn |
| Sep 30, 2022 | 30.06 Mn |
| Jun 30, 2022 | 29.94 Mn |
| Mar 31, 2022 | 28.39 Mn |
| Dec 31, 2021 | 17.55 Mn |
| Sep 30, 2021 | 17.48 Mn |
API Access
Relmada Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();